Current Treatments and Therapeutic Options for COVID-19 Patients: A Systematic Review - Archive ouverte HAL Access content directly
Journal Articles Infectious Disorders - Drug Targets Year : 2021

Current Treatments and Therapeutic Options for COVID-19 Patients: A Systematic Review

, , , , , , , , (1)
1
Esmaeil Mehraeen
Zeinab Najafi
  • Function : Author
Bagher Hayati
  • Function : Author
Mohammad Javaherian
  • Function : Author
Sajad Rahimi
  • Function : Author
Omid Dadras
  • Function : Author
Seyedahmad Seyedalinaghi
  • Function : Author
Maryam Ghadimi
  • Function : Author
Jean-Marc Sabatier

Abstract

Introduction: COVID-19 is the third rising epidemic in the 21st century that quickly turned into a worldwide pandemic. Many clinical studies have been achieved to investigate treatments to confrontation of COVID-19. Therefore, we conducted a systematic reviewto describe the recent treatment strategies to treat COVID-19 patients. Methods: A systematic search was performed in the databases of PubMed, Scopus, Embase, Science direct, Up to date, and Web of Science using the keywords of Coronavirus, COVID-19, SARS-CoV-2, Novel Coronavirus, 2019-nCoV, Treatment, Medicine, Therapy, Intervention, Drug, Medications, and Cure. Results: We included 58 studies including 38 articles (eleven reviews, ten editorial documents, three case reports, one mix method, one cohort study,) and 19 published clinical trials. Review of studies showed that Lopinavir/Ritonavir (n=16), Remdesivir (n=13), Convalescent plasma (n=11), Chloroquine (n=11), Ribavirin (n=9), Hydroxychloroquine sulfate (n=8), Traditional Chinese Medicine (TCM) (n=8), and Arbidol (n=7), were the most frequently used therapies used to treat COVID-19 patients. Conclusion: In the absence of definitive treatment protocols, recently proposed approaches appear to be an effective therapy for accelerating the recovery of COVID-19 patients. Some of these treatments may have been in the early stages of testing. However, future preclinical and clinical trials are warranted to validate findings.
Not file

Dates and versions

hal-03357937 , version 1 (29-09-2021)

Identifiers

Cite

Esmaeil Mehraeen, Zeinab Najafi, Bagher Hayati, Mohammad Javaherian, Sajad Rahimi, et al.. Current Treatments and Therapeutic Options for COVID-19 Patients: A Systematic Review. Infectious Disorders - Drug Targets, 2021, 21, ⟨10.2174/1871526521666210726150435⟩. ⟨hal-03357937⟩
11 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More